Credit Available: 0.75 AMA PRA Category 1 credit(s)™

Course Faculty: Andrew J. Solomon, MD

This activity will explore strategies for prompt and accurate differential diagnosis of MS to facilitate timely treatment initiation. Learners will gain updated insights into MS prevalence, pathophysiology, and the importance of early recognition and treatment. Guideline-based approaches for distinguishing MS from other demyelinating disorders such as neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein antibody-associated disease will be discussed. Additionally, emerging magnetic resonance imaging biomarkers that may aid in differential diagnosis will be highlighted.

Credit Available: 0.75 AMA PRA Category 1 credit(s)™

Course Faculty: Scott Newsome, DO, MSCS, FAAN, FANA (Course Director)

This activity will provide a comprehensive review of disease-modifying therapies for MS, encompassing both established treatments and the latest approved and emerging options. Learners will gain insights into the efficacy, safety profiles, and real-world impact of these therapies. Topics will include treatment selection (including discussions on treatment escalation vs early intensive therapy), optimal timing for high-efficacy therapies, strategies to prevent secondary progressive MS, and considerations for switching therapies. Emphasis will be placed on patient-centered management, including understanding individual patient priorities and balancing treatment efficacy, safety, and tolerability.

Credit Available: 0.75 AMA PRA Category 1 credit(s)™

Course Faculty: Lisa Fox, PA-C

This activity will focus on the importance of shared decision-making in managing multiple sclerosis MS and tailoring treatment plans to individual patient needs. Participants will explore the key elements of effective communication between healthcare providers and patients, including discussing treatment options, understanding risk tolerance, and addressing patient concerns and educational needs. Through interactive case discussions and examples from clinical practice, learners will gain insights into the collaborative approach necessary for optimizing MS care and improving patient outcomes.